Back to Search

PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy

Recruiting Observational Study
Any Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
700 (estimated)
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

PROACT is a prospective master protocol for a cohort study focused on evaluating the implementation of integrated proactive pathways of supportive care. This is an observational cohort study in the context of a quality-of-care initiative. It will be evaluated by its impact on patient's distress measured by the NCCN's Distress thermometer at 12 weeks after entering the pathway.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histological confirmation of cancer (any cancer type, any stage) * Age ≥ 18 years old * Received an integrated supportive care need assessment. * Sign the consent form for the PROACT study. Exclusion Criteria: * Absence or inability of written consent from the patient. * Doe…
Contacts

Maria Alice BORINELLI-FRANZOI

+33 (0)1 42 11 42 11

Mariaalice.BORINELLI-FRANZOI@gustaveroussy.fr

CONTACT

Aude BARBIER

+33 (0)6 44 12 47 75

aude.barbier@gustaveroussy.fr

CONTACT

NCT ID: NCT06479057 Source: ClinicalTrials.gov